nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aldose Reductase: a cause and a potential target for the treatment of diabetic complications
|
Thakur, Sapna |
|
|
44 |
7 |
p. 655-667 |
artikel |
2 |
Amyloidogenic, neuroinflammatory and memory dysfunction effects of HIV-1 gp120
|
Lee, Young-Jung |
|
|
44 |
7 |
p. 689-701 |
artikel |
3 |
Atractylenolides (I, II, and III): a review of their pharmacology and pharmacokinetics
|
Deng, Mao |
|
|
44 |
7 |
p. 633-654 |
artikel |
4 |
Ginsenoside-Rg2 exerts anti-cancer effects through ROS-mediated AMPK activation associated mitochondrial damage and oxidation in MCF-7 cells
|
Jeon, Hyesu |
|
|
44 |
7 |
p. 702-712 |
artikel |
5 |
Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis
|
Purja, Sujata |
|
|
44 |
7 |
p. 725-740 |
artikel |
6 |
Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson’s disease
|
Shin, Eun-Joo |
|
|
44 |
7 |
p. 668-688 |
artikel |
7 |
Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism
|
Kim, Young-Hoon |
|
|
44 |
7 |
p. 713-724 |
artikel |